Fatal T-cell lymphomas developed in three patients with a chronic illness manifested by fever, pneumonia, dysgammaglobulinemia, hematologic abnormalities, and extraordinarily high titers of antibody to the Epstein-Barr virus (EBV) capsid antigen (greater than 10,000) and early antigen (greater than 640) but low titers to the EBV nuclear antigen (less than or equal to 40). To understand the pathogenesis of these tumors better, we determined the immunophenotype of the tumor cells and analyzed tumor-cell DNA for EBV genomes and for lymphoid-cell gene rearrangements. More than 80 percent of the cells in tumors had an activated helper T-cell phenotype (T4, T11, la positive). The EBV genome was found by in situ hybridization in tumor tissue from each patient. Southern blot assay of DNA digests from one patient showed the same pattern as that of the EBV-infected marmoset line, B95-8. DNA digests from two patients showed a monoclonal proliferation of T cells determined on the basis of uniform T-cell-receptor gene rearrangements and a single band for the joined termini of the EBV genome. We conclude that EBV may infect T cells and contribute to lymphomas in selected patients with severe EBV infections.
Source Information
Pediatrics Department, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.
This article has been cited by other articles:
Perrine, S. P., Hermine, O., Small, T., Suarez, F., O'Reilly, R., Boulad, F., Fingeroth, J., Askin, M., Levy, A., Mentzer, S. J., Di Nicola, M., Gianni, A. M., Klein, C., Horwitz, S., Faller, D. V.
(2007). A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. Blood
109: 2571-2578
[Abstract][Full Text]
Dupuis, J., Emile, J.-F., Mounier, N., Gisselbrecht, C., Martin-Garcia, N., Petrella, T., Bouabdallah, R., Berger, F., Delmer, A., Coiffier, B., Reyes, F., Gaulard, P.
(2006). Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: a Groupe d'Etude des Lymphomes de l'Adulte (GELA) study. Blood
108: 4163-4169
[Abstract][Full Text]
Iwatsuki, K., Satoh, M., Yamamoto, T., Oono, T., Morizane, S., Ohtsuka, M., Xu, Z.-G., Suzuki, D., Tsuji, K.
(2006). Pathogenic link between hydroa vacciniforme and epstein-barr virus-associated hematologic disorders.. Arch Dermatol
142: 587-595
[Abstract][Full Text]
Chuang, H.-C., Lay, J.-D., Hsieh, W.-C., Wang, H.-C., Chang, Y., Chuang, S.-E., Su, I.-J.
(2005). Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood
106: 3090-3096
[Abstract][Full Text]
Kase, S., Adachi, H., Osaki, M., Murakami, M., Sairenji, T., Hashimoto, K., Teramoto, H., Yamamoto, S., Makino, H., Shimizu, E., Watanabe, T., Ohsawa, T., Hagari, Y., Mihara, M., Ito, H.
(2004). Epstein-Barr Virus-Infected Malignant T/NK-Cell Lymphoma in a Patient with Hypersensitivity to Mosquito Bites. INT J SURG PATHOL
12: 265-272
[Abstract]
Thompson, M. P., Kurzrock, R.
(2004). Epstein-Barr Virus and Cancer. Clin. Cancer Res.
10: 803-821
[Abstract][Full Text]
Arias, L. F., Hernandez, S., Prats, D., Sanchez-Fructoso, A., Marques, M., Alvarez, T., Barrientos, A., Blanco, J.
(2003). Epstein-Barr virus latency in kidney specimens from transplant recipients. Nephrol Dial Transplant
18: 2638-2643
[Abstract][Full Text]
Yoshioka, M., Kikuta, H., Ishiguro, N., Ma, X., Kobayashi, K.
(2003). Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection. J. Gen. Virol.
84: 1133-1140
[Abstract][Full Text]
Oyoshi, M. K., Nagata, H., Kimura, N., Zhang, Y., Demachi, A., Hara, T., Kanegane, H., Matsuo, Y., Yamaguchi, T., Morio, T., Hirano, A., Shimizu, N., Yamamoto, K.
(2003). Preferential Expansion of V{gamma}9-J{gamma}P/V{delta}2-J{delta}3 {gamma}{delta} T Cells in Nasal T-Cell Lymphoma and Chronic Active Epstein-Barr Virus Infection. Am. J. Pathol.
162: 1629-1638
[Abstract][Full Text]
Savoldo, B., Huls, M. H., Liu, Z., Okamura, T., Volk, H.-D., Reinke, P., Sabat, R., Babel, N., Jones, J. F., Webster-Cyriaque, J., Gee, A. P., Brenner, M. K., Heslop, H. E., Rooney, C. M.
(2002). Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection. Blood
100: 4059-4066
[Abstract][Full Text]
Xu, J., Ahmad, A., Menezes, J.
(2002). Preferential Localization of the Epstein-Barr Virus (EBV) Oncoprotein LMP-1 to Nuclei in Human T Cells: Implications for Its Role in the Development of EBV Genome-Positive T-Cell Lymphomas. J. Virol.
76: 4080-4086
[Abstract][Full Text]
Yoshioka, M., Ishiguro, N., Ishiko, H., Ma, X., Kikuta, H., Kobayashi, K.
(2001). Heterogeneous, restricted patterns of Epstein-Barr virus (EBV) latent gene expression in patients with chronic active EBV infection. J. Gen. Virol.
82: 2385-2392
[Abstract][Full Text]
Ferrari, M. G., Rivadeneira, E. D., Jarrett, R., Stevceva, L., Takemoto, S., Markham, P., Franchini, G.
(2001). HVMNE, a novel lymphocryptovirus related to Epstein-Barr virus, induces lymphoma in New Zealand White rabbits. Blood
98: 2193-2199
[Abstract][Full Text]
Kasahara, Y., Yachie, A., Takei, K., Kanegane, C., Okada, K., Ohta, K., Seki, H., Igarashi, N., Maruhashi, K., Katayama, K., Katoh, E., Terao, G., Sakiyama, Y., Koizumi, S.
(2001). Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood
98: 1882-1888
[Abstract][Full Text]
Kimura, H., Hoshino, Y., Kanegane, H., Tsuge, I., Okamura, T., Kawa, K., Morishima, T.
(2001). Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood
98: 280-286
[Abstract][Full Text]
Akpek, G., Akpek, E. K., Li, S., Green, R. W., O'Brien, T. P., Borowitz, M. J.
(2001). Unusual Locations for Lymphomas: Case 3. Successive Occurrence of Peripheral T-Cell Lymphoma With Bilateral Conjuctival Involvement in a Patient With Low-Grade B-Cell Lymphoma. JCO
19: 2964-2966
[Full Text]
Mraz-Gernhard, S., Natkunam, Y., Hoppe, R. T., LeBoit, P., Kohler, S., Kim, Y. H.
(2001). Natural Killer/Natural Killer-Like T-Cell Lymphoma, CD56+, Presenting in the Skin: An Increasingly Recognized Entity With an Aggressive Course. JCO
19: 2179-2188
[Abstract][Full Text]
Cohen, J. I.
(2000). Epstein-Barr Virus Infection. NEJM
343: 481-492
[Full Text]
Quintanilla-Martinez, L., Kumar, S., Fend, F., Reyes, E., Teruya-Feldstein, J., Kingma, D. W., Sorbara, L., Raffeld, M., Straus, S. E., Jaffe, E. S.
(2000). Fulminant EBV+ T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood
96: 443-451
[Abstract][Full Text]
Dreyfus, D. H., Nagasawa, M., Kelleher, C. A., Gelfand, E. W.
(2000). Stable expression of Epstein-Barr virus BZLF-1-encoded ZEBRA protein activates p53-dependent transcription in human Jurkat T-lymphoblastoid cells. Blood
96: 625-634
[Abstract][Full Text]
Dreyfus, D. H., Nagasawa, M., Pratt, J. C., Kelleher, C. A., Gelfand, E. W.
(1999). Inactivation of NF-{kappa}B by EBV BZLF-1-Encoded ZEBRA Protein in Human T Cells. J. Immunol.
163: 6261-6268
[Abstract][Full Text]
Skolnik, P. R., Mark, E. J.
(1999). Case 5-1999- A 37-Year-Old Man with Fever and Diffuse Lymphadenopathy. NEJM
340: 545-554
[Full Text]
Kanegane, H., Bhatia, K., Gutierrez, M., Kaneda, H., Wada, T., Yachie, A., Seki, H., Arai, T., Kagimoto, S.-i., Okazaki, M., Oh-ishi, T., Moghaddam, A., Wang, F., Tosato, G.
(1998). A Syndrome of Peripheral Blood T-Cell Infection With Epstein-Barr Virus (EBV) Followed by EBV-Positive T-Cell Lymphoma. Blood
91: 2085-2091
[Abstract][Full Text]
Quintanilla-Martinez, L., Lome-Maldonado, C., Ott, G., Gschwendtner, A., Gredler, E., Reyes, E., Angeles-Angeles, A., Fend, F.
(1997). Primary Non-Hodgkin's Lymphoma of the Intestine: High Prevalence of Epstein-Barr Virus in Mexican Lymphomas as Compared With European Cases. Blood
89: 644-651
[Abstract][Full Text]
(1988). EPSTEIN-BARR VIRUS AND T-CELL LYMPHOMA. JWatch General
1988: 8-8
[Full Text]
Previous
